Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 17, Number 12—December 2011

Dispatch

Seroprevalence of Alkhurma and Other Hemorrhagic Fever Viruses, Saudi Arabia

Ziad A. MemishComments to Author , Ali Albarrak, Mohammad A. Almazroa, Ibrahim Al-Omar, Rafat Alhakeem, Abdullah Assiri, Shamsudeen Fagbo, Adam MacNeil, Pierre E. Rollin, Nageeb Abdullah, and Gwen Stephens
Author affiliations: Ministry of Health, Riyadh, Kingdom of Saudi Arabia (Z.A. Memish, M.A. Almazroa, I. Al-Omar, R. Alhakeem, A. Assiri, S. Fagbo, N. Abdullah, G. Stephens); Riyadh Military Hospital, Riyadh (A. Albarrak); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (A. MacNeil, P.E. Rollin); University of British Columbia, Vancouver, British Columbia, Canada (G. Stephens)

Main Article

Table

Serologic status of 1,024 soldiers evaluated for IgG and IgM ELISA reactivity against AHFV, CCHF, DENV, and RVFV antigens, Saudi Arabia, 2009*

Virus No. (%) IgG reactive No. IgM reactive No. symptomatic Seroprevalence/100 soldiers tested
RVFV 20 (2.0) 1 1 (rash) 1.95
AHFV 13 (1.3) 0 0 1.27
CCHF 6 (0.6) 0 0 0.58
DENV 1 (0.1) 0 0 0.1
Total 40 (3.9) 1 1 3.9

*AHFV, Alkhurma hemorrhagic fever virus; CCHF, Crimean-Congo hemorrhagic fever; DENV, dengue virus; RVFV, Rift Valley fever virus.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO